Business
Press Release Aug 21 2024
Indoco Remedies Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation".
About this update from Indoco Remedies Limited
[{"type":"text","content":" Indoco Remedies Limited has informed the Exchange regarding a press release dated August 21, 2024, titled \"Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation\". View Attachment","length":386,"tagName":"div"}]